Skip to main content
Erschienen in: Critical Care 5/2013

01.10.2013 | Letter

3,4-Diaminopyridine may improve neuromuscular block during botulism

verfasst von: Arnaud Friggeri, Frédéric Marçon, Sandra Marciniak, Anne-Sophie Lemaire-Hurtel, Abdoul Aziz Seydi, Nacim Ammenouche, Mélanie Levrard, Yazine Mahjoub, Norik Airapetian, François Tinturier, Michel Petitjean, Hervé Dupont

Erschienen in: Critical Care | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Excerpt

In September 2011, two outbreaks of botulism toxemia (toxin A) incriminating the same artisanal product were responsible for nine cases of botulism in France. Among these cases, three women (Cases 1, 2, and 3) aged 27, 29, and 23 years, respectively, were hospitalized in our ICU for mechanical ventilation support. They rapidly received a trivalent botulism antitoxin serum. Two weeks later, Case 3 passed a spontaneous breathing trial but needed new ventilator support 24 hours after extubation. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kongsaengdao S, Samintarapanya K, Rusmeechan S, Wongsa A, Pothirat C, Permpikul C, Pongpakdee S, Puavilai W, Kateruttanakul P, Phengtham U, Panjapornpon K, Janma J, Piyavechviratana K, Sithinamsuwan P, Deesomchok A, Tongyoo S, Vilaichone W, Boonyapisit K, Mayotarn S, Piya-Isragul B, Rattanaphon A, Intalapaporn P, Dusitanond P, Harnsomburana P, Laowittawas W, Chairangsaris P, Suwantamee J, Wongmek W, Ratanarat R, Poompichate A, et al.: An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis 2006, 43: 1247-1256. 10.1086/508176CrossRefPubMed Kongsaengdao S, Samintarapanya K, Rusmeechan S, Wongsa A, Pothirat C, Permpikul C, Pongpakdee S, Puavilai W, Kateruttanakul P, Phengtham U, Panjapornpon K, Janma J, Piyavechviratana K, Sithinamsuwan P, Deesomchok A, Tongyoo S, Vilaichone W, Boonyapisit K, Mayotarn S, Piya-Isragul B, Rattanaphon A, Intalapaporn P, Dusitanond P, Harnsomburana P, Laowittawas W, Chairangsaris P, Suwantamee J, Wongmek W, Ratanarat R, Poompichate A, et al.: An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure. Clin Infect Dis 2006, 43: 1247-1256. 10.1086/508176CrossRefPubMed
2.
Zurück zum Zitat Zhang JC, Sun L, Nie QH: Botulism, where are we now? Clin Toxicol (Phila) 2010, 48: 867-879. 10.3109/15563650.2010.535003CrossRef Zhang JC, Sun L, Nie QH: Botulism, where are we now? Clin Toxicol (Phila) 2010, 48: 867-879. 10.3109/15563650.2010.535003CrossRef
3.
Zurück zum Zitat Adler M, Capacio B, Deshpande SS: Antagonism of botulinum toxin A-mediated muscle paralysis by 3,4-diaminopyridine delivered via osmotic minipumps. Toxicon 2000, 38: 1381-1388. 10.1016/S0041-0101(99)00231-7CrossRefPubMed Adler M, Capacio B, Deshpande SS: Antagonism of botulinum toxin A-mediated muscle paralysis by 3,4-diaminopyridine delivered via osmotic minipumps. Toxicon 2000, 38: 1381-1388. 10.1016/S0041-0101(99)00231-7CrossRefPubMed
4.
Zurück zum Zitat McEvoy KM, Windebank AJ, Daube JR, Low PA: 3,4-diaminopyridine in the treatment of Lambert Eaton myasthenic syndrome. N Engl J Med 1989, 321: 1567-1571. 10.1056/NEJM198912073212303CrossRefPubMed McEvoy KM, Windebank AJ, Daube JR, Low PA: 3,4-diaminopyridine in the treatment of Lambert Eaton myasthenic syndrome. N Engl J Med 1989, 321: 1567-1571. 10.1056/NEJM198912073212303CrossRefPubMed
Metadaten
Titel
3,4-Diaminopyridine may improve neuromuscular block during botulism
verfasst von
Arnaud Friggeri
Frédéric Marçon
Sandra Marciniak
Anne-Sophie Lemaire-Hurtel
Abdoul Aziz Seydi
Nacim Ammenouche
Mélanie Levrard
Yazine Mahjoub
Norik Airapetian
François Tinturier
Michel Petitjean
Hervé Dupont
Publikationsdatum
01.10.2013
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 5/2013
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc12880

Weitere Artikel der Ausgabe 5/2013

Critical Care 5/2013 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.